Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

FibroGen Inc (FGEN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow FibroGen Inc's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.150 -0.020    -1.71%
16:00:01 - Closed. Currency in USD ( Disclaimer )
After Hours
1.140
-0.010
-0.870%
17:31:11 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 1,310,555
  • Bid/Ask: 1.090 / 1.140
  • Day's Range: 1.050 - 1.180
FibroGen Inc 1.150 -0.020 -1.71%

FibroGen Inc Company Profile

 
Get an in-depth profile of FibroGen Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

592

Equity Type

ORD

FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. Its lead product candidates are Pamrevlumab, a human monoclonal antibody targeting connective tissue growth factor that is in Phase III clinical development for the treatment of locally advanced pancreatic cancer; and Roxadustat, an oral small molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase activity, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in China, Europe, Japan, and other countries, as well as in Phase III clinical development for anemia related with myelodysplastic syndromes. The company has collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. FibroGen, Inc. was incorporated in 1993 and is headquartered in San Francisco, California.

Contact Information

Address 409 Illinois Street
San Francisco, 94158
United States
Phone 415 978 1200
Fax 415 978 1902

Top Executives

Name Age Since Title
James A. Schoeneck 64 2010 Independent Chairman of the Board
George R. Martin - - Chairman of Scientific Advisory Board
Jeffrey W. Henderson 58 2015 Independent Director
Suzanne Blaug 65 2019 Independent Director
Aoife M. Brennan 47 2020 Independent Director
Gerald Lema 62 2017 Independent Director
Benjamin F. Cravatt 53 2020 Independent Director
Jeffrey L. Edwards 62 2015 Independent Director
Maykin Ho 70 2018 Independent Director
Thane Wettig 58 2020 CEO & Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

FGEN Comments

Write your thoughts about FibroGen Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Shahid Khan
Shahid Khan Mar 13, 2024 11:02AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Yay still holding 14k shares @ $3
Ryan Watkins
Ryan Watkins Feb 10, 2024 6:06PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
ugh why fibrogen instead of vicarious surgical
Shahid Khan
Shahid Khan Jan 24, 2024 10:53AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I have 14k shares bought at $3
Anthony Hernandez
Anthony Hernandez Aug 04, 2023 2:17PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
You got this Jenna. You are going to buy a cute fit when this hits $10 bucks :)
Jenna Ragan
Jenna Ragan Jul 26, 2023 2:18PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I got me 50 shares. looking to make some money 🤑
pelin akinci
pelin akinci Jun 29, 2023 3:29AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
1688023733_21260.jpg
upper
Vlas Dacian
Vlas Dacian Jun 26, 2023 8:33AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy some around 2$
Anthony Hernandez
Anthony Hernandez Jun 23, 2022 7:52PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
ya baby
Anthony Hernandez
Anthony Hernandez Jun 07, 2022 10:34PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Should be $30 and will be here soon
Марин Андрей
Марин Андрей Oct 07, 2021 9:24AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Lets start!
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email